IRD

Opus Genetics, Inc.$4.27-0.17 (-3.83%)

Prev Close$4.44·MCap$359.2M·P/E—·Vol563.4K·Yield—

▲

Buys (12M)

$323.7K

▼

Sells (12M)

$9.00M

◆

Net Activity

Net Seller

$8.68M

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Opus Genetics, Inc. (IRD) has been dominated by selling, with 1 insider purchase totaling $323.7K and 12 insider sales totaling $9.00M. The most recent insider transaction was by YERXA BENJAMIN R (director, officer: President), who sold $39.1K worth of shares on Apr 27, 2026. Opus Genetics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $359.2M.

IRD Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Apr 27, 2026	YERXA BENJAMIN R	director, officer: President	Sell	7,470	$5.24	$39.1K	711,535
Apr 27, 2026	Gagnon Robert E.	officer: Chief Financial Officer	Sell	7,842	$5.18	$40.7K	592,158
Apr 27, 2026	Magrath George	director, officer: Chief Executive Officer	Sell	9,511	$5.22	$49.6K	1,741,344
Apr 27, 2026	SCHACHLE JOSEPH K	officer: Chief Operating Officer	Sell	4,697	$5.22	$24.5K	296,084
Apr 27, 2026	Zaremba Rabourn Amy	officer: Head of Fin. Quality Assurance	Sell	1,641	$5.20	$8.5K	188,671
Apr 27, 2026	Jayagopal Ashwath	officer: Chief Scientific & Dev. Ofc.	Sell	7,542	$5.19	$39.2K	509,233
Mar 18, 2026	Jayagopal Ashwath	officer: Chief Scientific & Dev. Ofc.	Sell	3,719	$5.12	$19.0K	516,775
Mar 18, 2026	Magrath George	director, officer: Chief Executive Officer	Sell	24,438	$5.21	$127.3K	1,750,855
Mar 18, 2026	SCHACHLE JOSEPH K	officer: Chief Operating Officer	Sell	3,719	$5.25	$19.5K	300,781
Mar 18, 2026	Zaremba Rabourn Amy	officer: Head of Fin. Quality Assurance	Sell	2,816	$5.24	$14.8K	190,312
Feb 12, 2026	Jayagopal Ashwath	Chief Scientific & Dev. Ofc.	Sell	5,313	$3.39	$18.0K	0
Dec 31, 2025	Gallagher Cam		Buy	164,000	$1.97	$323.7K	1,891,430
Dec 11, 2025	Foundation Fighting Blindness Retinal Degeneration Fund	Director	Sell	4,000,000	$2.15	$8.60M5.6% OS	5,492,171-42%
Dec 30, 2024	Magrath George	Chief Executive Officer	Buy	100,000	$0.98	$97.6K	599,150
Nov 25, 2024	YERXA BENJAMIN R	President	Buy	10,000	$0.98	$9.8K	342,800
Nov 19, 2024	Magrath George	Chief Executive Officer	Buy	100,000	$1.01	$101.2K	492,950+25%
May 24, 2024	Jayagopal Ashwath	Chief Scientific & Dev. Ofc.	Buy	3,500	$1.77	$6.2K	78,500
May 21, 2024	Magrath George	Chief Executive Officer	Buy	5,000	$1.75	$8.8K	430,000
Mar 25, 2024	Jhaveri Nirav S.	Chief Financial Officer	Buy	10,000	$2.10	$21.0K	150,000
Mar 25, 2024	SCHACHLE JOSEPH K	Chief Operating Officer	Buy	2,000	$2.05	$4.1K	2,000
Mar 20, 2024	Magrath George	Chief Executive Officer	Buy	25,000	$1.96	$49.0K	425,000
May 24, 2022	MANUSO JAMES S J		Buy	5,000	$1.99	$9.9K	21,570+30%
May 23, 2022	Sooch Mina	President and CEO	Buy	25,000	$2.05	$51.2K	425,022
Dec 14, 2021	Pepose Jay		Buy	8,250	$3.65	$30.1K	22,994+56%
Nov 22, 2021	MANUSO JAMES S J		Buy	2,000	$3.50	$7.0K	16,570
Sep 15, 2021	Pepose Jay		Buy	12,631	$4.75	$60.0K	14,744+598%
Sep 3, 2021	Benton Susan		Buy	20,000	$4.57	$91.4K	23,976+503%

IRD Insider Buying Activity

The following table shows recent insider purchases of Opus Genetics, Inc. (IRD) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Dec 31, 2025	Gallagher Cam		Buy	164,000	$1.97	$323.7K	1,891,430
Dec 30, 2024	Magrath George	Chief Executive Officer	Buy	100,000	$0.98	$97.6K	599,150
Nov 25, 2024	YERXA BENJAMIN R	President	Buy	10,000	$0.98	$9.8K	342,800
Nov 19, 2024	Magrath George	Chief Executive Officer	Buy	100,000	$1.01	$101.2K	492,950+25%
May 24, 2024	Jayagopal Ashwath	Chief Scientific & Dev. Ofc.	Buy	3,500	$1.77	$6.2K	78,500
May 21, 2024	Magrath George	Chief Executive Officer	Buy	5,000	$1.75	$8.8K	430,000
Mar 25, 2024	Jhaveri Nirav S.	Chief Financial Officer	Buy	10,000	$2.10	$21.0K	150,000
Mar 25, 2024	SCHACHLE JOSEPH K	Chief Operating Officer	Buy	2,000	$2.05	$4.1K	2,000
Mar 20, 2024	Magrath George	Chief Executive Officer	Buy	25,000	$1.96	$49.0K	425,000
May 24, 2022	MANUSO JAMES S J		Buy	5,000	$1.99	$9.9K	21,570+30%
May 23, 2022	Sooch Mina	President and CEO	Buy	25,000	$2.05	$51.2K	425,022
Dec 14, 2021	Pepose Jay		Buy	8,250	$3.65	$30.1K	22,994+56%
Nov 22, 2021	MANUSO JAMES S J		Buy	2,000	$3.50	$7.0K	16,570
Sep 15, 2021	Pepose Jay		Buy	12,631	$4.75	$60.0K	14,744+598%
Sep 3, 2021	Benton Susan		Buy	20,000	$4.57	$91.4K	23,976+503%

IRD Insider Selling Activity

The following table shows recent insider sales of Opus Genetics, Inc. (IRD) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Apr 27, 2026	YERXA BENJAMIN R	director, officer: President	Sell	7,470	$5.24	$39.1K	711,535
Apr 27, 2026	Gagnon Robert E.	officer: Chief Financial Officer	Sell	7,842	$5.18	$40.7K	592,158
Apr 27, 2026	Magrath George	director, officer: Chief Executive Officer	Sell	9,511	$5.22	$49.6K	1,741,344
Apr 27, 2026	SCHACHLE JOSEPH K	officer: Chief Operating Officer	Sell	4,697	$5.22	$24.5K	296,084
Apr 27, 2026	Zaremba Rabourn Amy	officer: Head of Fin. Quality Assurance	Sell	1,641	$5.20	$8.5K	188,671
Apr 27, 2026	Jayagopal Ashwath	officer: Chief Scientific & Dev. Ofc.	Sell	7,542	$5.19	$39.2K	509,233
Mar 18, 2026	Jayagopal Ashwath	officer: Chief Scientific & Dev. Ofc.	Sell	3,719	$5.12	$19.0K	516,775
Mar 18, 2026	Magrath George	director, officer: Chief Executive Officer	Sell	24,438	$5.21	$127.3K	1,750,855
Mar 18, 2026	SCHACHLE JOSEPH K	officer: Chief Operating Officer	Sell	3,719	$5.25	$19.5K	300,781
Mar 18, 2026	Zaremba Rabourn Amy	officer: Head of Fin. Quality Assurance	Sell	2,816	$5.24	$14.8K	190,312
Feb 12, 2026	Jayagopal Ashwath	Chief Scientific & Dev. Ofc.	Sell	5,313	$3.39	$18.0K	0
Dec 11, 2025	Foundation Fighting Blindness Retinal Degeneration Fund	Director	Sell	4,000,000	$2.15	$8.60M5.6% OS	5,492,171-42%